Mycophenolate (e.g. CellCept®): Strengthening of warnings in order to prevent use during pregnancy
2015.10.26
Active substance: mycophenolate
The European Medicines Agency (EMA) has issued a warning that the active substance mycophenolate used in transplantation medicine must not be administered during pregnancy if other treatment alternatives are available.
To the risk information - full text (available in German only)